• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Pioneer Floating Rate

Pioneer Floating Rate

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. R-Tech Ueno: Announcement on Completion of the Phase I Single-Dose Clinical Trial for the Novel VAP-1 Inhibitor RTU-1096

    R-Tech Ueno: Announcement on Completion of the Phase I Single-Dose Clinical Trial for the Novel VAP-1 Inhibitor RTU-1096

  2. Pioneer Investments Declares Monthly Distributions for Closed-End Funds

    Pioneer Investments Declares Monthly Distributions for Closed-End Funds

  3. Sunovion Announces Health Outcomes Data that Support the Consideration of Brovana® (arformoterol tartrate) Inhalation Solution for the Maintenance Treatment of COPD at the American Thoracic Society ...

    Sunovion Announces Health Outcomes Data that Support the Consideration of Brovana® (arformoterol tartrate) Inhalation Solution for the Maintenance Treatment of COPD at the American Thoracic Society (ATS) 2015 Annual Meeting

  4. Silvercorp reports financial and operating results for the fiscal year and fourth quarter ended March 31, 2015

    Silvercorp reports financial and operating results for the fiscal year and fourth quarter ended March 31, 2015

  5. Trimble Introduces Autonomous Operation Support in its ThingMagic Mercury API

    Trimble Introduces Autonomous Operation Support in its ThingMagic Mercury API

  6. TheraCell, Inc. (Los Angeles) Announces Appointment of Dr. Gunnar Andersson to Its Board of Directors and Surgeon Advisory Board

    TheraCell, Inc. (Los Angeles) Announces Appointment of Dr. Gunnar Andersson to Its Board of Directors and Surgeon Advisory Board

  7. TMA PracticeEdge Signs Innovista Health Solutions to Power ACO Services for Physicians

    TMA PracticeEdge Signs Innovista Health Solutions to Power ACO Services for Physicians

  8. Cellanyx Diagnostics Announces Expanded Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

    Cellanyx Diagnostics Announces Expanded Clinical Data with a Novel Live Tumor Cell, Phenotypic Biomarker Test in Prostate Cancer

  9. Direct Flow Medical(R) Reports Excellent Two Year Data for Its Transcatheter Aortic Heart Valve System

    Direct Flow Medical(R) Reports Excellent Two Year Data for Its Transcatheter Aortic Heart Valve System

  10. Flow Forward Closes $1.3 Million of Additional Series A Financing and Appoints Kurt Dasse to the Board of Directors

    Flow Forward Closes $1.3 Million of Additional Series A Financing and Appoints Kurt Dasse to the Board of Directors

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.